G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage

Neurochemistry International
M OrthJ M Cooper

Abstract

Alpha synuclein protein may play an important role in familial and sporadic Parkinson's disease pathology. We have induced G209A mutant or wild-type alpha-synuclein expression in stable HEK293 cell models to determine if this influences markers of oxidative stress and damage under normal conditions or in the presence of dopamine or paraquat. Induced wild-type or mutant alpha-synuclein expression alone had no effect upon levels of oxidative stress or damage, as measured by glutathione levels or aconitase activity. Both wild-type and mutant alpha-synuclein expression decreased the oxidative damage induced by paraquat, although the protection was less marked with mutant alpha-synuclein expression. This suggests that alpha-synuclein expression may either have anti-oxidant properties or may upregulate cellular antioxidant levels, a function that was diminished by the G209A mutation. However, mutant but not wild-type alpha-synuclein expression specifically enhanced dopamine associated oxidative damage. Non-expressing cells treated with reserpine to inhibit the vesicular monoamine compartmentalisation produced similar results. However, consistent with the hypothesis that mutant alpha-synuclein disrupts vesicular dopamine compartmental...Continue Reading

Citations

Aug 31, 2012·Molecular Neurobiology·Blanca A SilvaVladimir N Uversky
Jan 31, 2013·Molecular Neurobiology·Stephen Mullin, Anthony Schapira
Mar 26, 2010·BMC Neuroscience·Marco BisagliaLuigi Bubacco
Mar 17, 2010·Biochemical and Biophysical Research Communications·Marco BisagliaLuigi Bubacco
Mar 25, 2008·Biochimica Et Biophysica Acta·Shankar J Chinta, Julie K Andersen
Nov 22, 2005·Neurobiology of Disease·Peter KlivenyiM Flint Beal
Jun 27, 2012·Nutritional Neuroscience·Jhon Jairo SutachanGeorge E Barreto
Jul 26, 2012·Oxidative Medicine and Cellular Longevity·Mustafa VarçinSophie Sarre
Apr 3, 2015·Oxidative Medicine and Cellular Longevity·Roman Fischer, Olaf Maier
Dec 17, 2008·International Review of Cell and Molecular Biology·Andrei Surguchov
Nov 7, 2012·Cell Transplantation·Hueng-Chuen FanShinn-Zong Lin
Dec 31, 2014·Experimental Neurobiology·Edith Sturm, Nadia Stefanova
Oct 9, 2019·Cell Death and Differentiation·Maritza OñateFelipe A Court
Sep 22, 2007·Neuroreport·Wen-Wei LiDing-Fang Cai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

© 2022 Meta ULC. All rights reserved